Author: Samantha Budd
OKYO Pharma Limited – Interim Results for the Six Months Ending 30 September 2022
Posted by Samantha Budd | Jan 5, 2023 | Articles, News |
OKYO Pharma Limited (LSE: OKYO, NASDAQ: OKYO), an ophthalmology-focused bio-pharmaceutical company...
Read MoreOKYO Pharma Limited – Interim Results for the Six Months Ending 30 September 2022
Posted by Samantha Budd | Jan 5, 2023 | Articles, News |
OKYO Pharma Limited (LSE: OKYO, NASDAQ: OKYO), an ophthalmology-focused bio-pharmaceutical company...
Read More